8446 Federal Register / Vol. 78, No. 25 / Wednesday, February 6, 2013 / Proposed Rules 

RUS will require Primary Recipients to 

evaluate each action taken with an 

Ultimate Recipient to ensure 

consistency with the terms of the 

executed program alternative. 

Primary Recipients will be 

responsible for documenting activities 

that fall below the established 

threshold. RUS will review the Primary 

Recipient’s documentation of actions 

that fall below the threshold prior to 

providing reimbursement with Federal 

funds. 

Any EE Program activity for which 

exemptions and standard treatments are 

not applicable would be subject to 

Section 106 review under procedures 

established by the PA or other program 

alternative. Therefore, the program 

alternative must define a clear threshold 

for RUS involvement in Section 106 

review. 

Although few in number, the 

comments on the Conceptual Outline 

received thus far have been supportive 

of the development of a nationwide PA, 

the need for streamlining, especially 

given the large number of reviews 

expected to be generated by EE Program 

activities, and the approach reflected in 

the Conceptual Outline. Based on these 

comments, RUS is proceeding with 

development of the first draft of the 

nationwide PA. The program alternative 

will be executed prior to RUS issuing a 

finding of no significant impact 

(FONSI). Both the FONSI and 

documents related to the program 

alternative will be made available to the 

public on RUS’s Web site at http:// 

www.rurdev.usda.gov/UWP-ea.htm. 

Dated: January 29, 2013. 

Nivin Elgohary, 

Assistant Administrator, Electric Programs, 

USDA, Rural Utilities Service. 

[FR Doc. 2013–02393 Filed 2–5–13; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF TRANSPORTATION 

Federal Aviation Administration 

14 CFR Part 39 

[Docket No. FAA–2013–0013; Directorate 

Identifier 2012–CE–046–AD] 

RIN 2120–AA64 

Airworthiness Directives; GROB– 

WERKE Airplanes 

AGENCY: Federal Aviation 

Administration (FAA), DOT. 

ACTION: Proposed rule; correction. 

SUMMARY: The FAA is correcting a 

Notice of Proposed Rulemaking (NPRM) 

that published in the Federal Register. 

That NPRM applies to all GROB– 

WERKE Model G115EG airplanes. The 

docket number in the preamble and in 

the section titled PART 39— 

AIRWORTHINESS DIRECTIVES, 

paragraph 2, is incorrect. This document 

corrects that error. In all other respects, 

the original document remains the 

same. 

DATES: The last date for submitting 

comments to the NPRM (78 FR 2910, 

January 15, 2013) remains March 1, 

2013. 

ADDRESSES: You may examine the AD 

docket on the Internet at http:// 

www.regulations.gov; or in person at 

the Docket Management Facility 

between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal holidays. 

The AD docket contains this AD, the 

regulatory evaluation, any comments 

received, and other information. The 

address for the Docket Office (phone: 

800–647–5527) is Document 

Management Facility, U.S. Department 

of Transportation, Docket Operations, 

M–30, West Building Ground Floor, 

Room W12–140, 1200 New Jersey 

Avenue SE., Washington, DC 20590. 

FOR FURTHER INFORMATION CONTACT: 

Taylor Martin, Aerospace Engineer, 

FAA, Small Airplane Directorate, 901 

Locust, Room 301, Kansas City, 

Missouri 64106; telephone: (816) 329– 

4138; fax: (816) 329–4090; email: 

taylor.martin@faa.gov. 

SUPPLEMENTARY INFORMATION: Notice of 

Proposed Rulemaking (NPRM), 

Directorate Identifier 2012–CE–046–AD 

(78 FR 2910, January 15, 2013), 

currently proposes to require 

inspections of the elevator trim tab arms 

for cracks and replacement if necessary. 

As published, the docket number in 

the preamble and in the section titled 

PART 39—AIRWORTHINESS 

DIRECTIVES, paragraph 2, is incorrect. 

No other part of the preamble or 

regulatory information has been 

changed; therefore, only the changed 

portion of the NPRM is being published 

in the Federal Register. 

The last date for submitting comments 

to the NPRM remains March 1, 2013. 

Correction of Non-Regulatory Text 

In the Federal Register of January 15, 

2013, Directorate Identifier 2012–CE– 

046–AD is corrected as follows: 

On page 2910, in the 2nd column, on 

line 4 under the preamble (below 

DEPARTMENT OF 

TRANSPORTATION), change Docket 

No. to ‘‘FAA–2013–0013.’’ 

Correction of Regulatory Text 

§ 39.13 [Corrected] 

■ In the Federal Register of January 15, 

2013, on page 2911, in the 3rd column, 

on line 20, in paragraph (2) under PART 

39—AIRWORTHINESS DIRECTIVES of 

Directorate Identifier 2012–CE–046–AD 

is corrected to read as follows: 

* * * * * 

* * * ‘‘FAA–2013–0013;’’ 

* * * * * 

Issued in Kansas City, Missouri, on January 

28, 2013. 

Earl Lawrence, 

Manager, Small Airplane Directorate, Aircraft 

Certification Service. 

[FR Doc. 2013–02578 Filed 2–5–13; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Parts 201, 314, and 601 

[Docket No. FDA–2013–N–0059] 

Center for Drug Evaluation and 

Research; Prescription Drug Labeling 

Improvement and Enhancement 

Initiative; Request for Comments and 

Information 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notification of an initiative; 

request for comments and information. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

establishment of a docket to receive 

comments on the proposed 

implementation of FDA’s Prescription 

Drug Labeling Improvement and 

Enhancement Initiative and on a 

proposed pilot project relating to the 

voluntary conversion of labeling to the 

‘‘Physician Labeling Rule (PLR)’’ format 

described in the 2006 FDA final rule, 

‘‘Requirements on Content and Format 

of Labeling for Human Prescription 

Drug and Biological Products.’’ The 

purpose of the initiative and the pilot 

project is to enhance the safe and 

effective use of prescription drugs by 

facilitating optimal communication 

through labeling. FDA is seeking public 

comment on this initiative, and the pilot 

project, particularly from stakeholders 

who develop and use prescription drug 

labeling. Comments received from 

stakeholders will assist the Agency in 

identifying and addressing feasibility 

and implementation issues associated 

with this initiative. 


srobinson on DSK4SPTVN1PROD with PROPOSALS